Author + information
- Received January 17, 2018
- Revision received April 28, 2018
- Accepted April 30, 2018
- Published online June 27, 2018.
- Gordon Ho, MDa,∗∗ (, )
- Oscar Ö. Braun, MDa,b,∗,
- Eric D. Adler, MDa,
- Gregory K. Feld, MDa,
- Victor G. Pretorius, MBChBc and
- Ulrika Birgersdotter-Green, MDa
- aDepartment of Medicine − Division of Cardiology, University of California, San Diego, San Diego, California
- bDepartment of Cardiology, Clinical Sciences, Lund University and Skane University Hospital, Lund, Sweden
- cDepartment of Cardiothoracic Surgery, University of California, San Diego, San Diego, California
- ↵∗Address for correspondence:
Dr. Gordon Ho, Department of Medicine – Division of Cardiology, University of California, San Diego, 9452 Medical Center Drive, MC 7411, La Jolla, California 92037.
For patients with end-stage heart failure, the use of mechanical circulatory support has increased in the last decade due to improved outcomes with durable left ventricular assist devices. The management of these complex patients requires coordinated care by a multidisciplinary team including cardiac electrophysiologists because atrial and ventricular arrhythmias are prevalent in this population. There have been an increasing number of studies that attempt to address issues regarding arrhythmia management in patients with left ventricular assist devices. The purpose of this review is to provide electrophysiologists with an evidence-based approach to manage a broad spectrum of arrhythmia issues in these patients.
- atrial arrhythmia
- cardiac implantable electronic device
- catheter ablation
- congestive heart failure
- left ventricular assist device
- ventricular arrhythmia
↵∗ Drs. Ho and Braun contributed equally to this work and are joint first authors.
Dr. Braun is supported by the Swedish Heart-Lung Foundation, the Crafoords Foundation, Märta Winklers Stiftelse and Thorsten Westerströms Stiftelse, ALF Grants Region Skåne. Dr. Ho received fellowship support from Boston Scientific, Biotronik and Medtronic; and has equity in Vektor Medical Inc. Dr. Adler is a consultant for Medtronic and Abbott. Dr. Feld receives CCEP Fellowship Training Program stipends from Medtronic, Boston Scientific, St. Jude, Biotronik, and Biosense Webster; has ownership equity in Perminova; and received research grants from Catheter Precision and Circa Scientific. Dr. Pretorius is a consultant for Medtronic and Abbott. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
All authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Clinical Electrophysiology author instructions page.
- Received January 17, 2018.
- Revision received April 28, 2018.
- Accepted April 30, 2018.
- 2018 American College of Cardiology Foundation
This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click Login or the Subscribe link (top menu above) to access this article.